About
Alexza Pharmaceuticals developed inhalation-based drug delivery technologies, including the Staccato system, and commercialized Adasuve, an inhaled treatment for acute agitation in schizophrenia and bipolar disorder. The company is now rebranded as Nova Pneuma, Inc.
Explore Alexza Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.